Founded in 2019, Aseptikits, LLC is a small, privately held, medical device company that researches, develops, patents, manufactures, and sells new products based on patented technologies.

The Aseptikits’ organizational partners have over 150 years of combined experience in the medical device and pharmacy space. This enables a vast depth of understanding of FDA regulations, standards relative to USP, medical devices, quality assurance and good manufacturing practices.

The amount of Bevacizumab (Avastin®) injected is 0.05ml.